[180 Pages Research Report] The global Neuromodulation Devices Market size was valued at USD 5.4 billion in 2022, and the market is projected to reach USD 11.4 billion by the end of 2023, with growth at a CAGR of 10.8% during the forecast report 2023-2030.
Medical equipment known as "neuromodulation devices" alter or control the nervous system's functioning through the use of electrical or chemical stimulation. These devices were created to treat a range of medical ailments, such as depression, epilepsy, movement disorders, and chronic pain.
Spinal cord stimulators, deep brain stimulators, vague nerve stimulators, and transcranial magnetic stimulation devices are a few examples of neuromodulation equipment. Under the skin implanted spinal cord stimulators employ electrical stimulation to block pain impulses before they reach the brain. Deep brain stimulators offer electrical stimulation to particular regions of the brain to treat movement disorders like Parkinson's disease. Epilepsy and depression are treated with vague nerve stimulators, which are surgically placed in the neck.
Neuromodulation devices have a number of benefits over traditional therapy for various illnesses. For example, they can treat pain without the use of opioids, which can lead to addiction and have other negative effects. Additionally, they may be less dangerous than surgery and, in certain cases, even more effective than medication.
Devices for neuromodulation, however, may come with some risks and limitations. For instance, they require surgery for implantation, which has inherent dangers. Additionally, some patients may experience adverse side effects such as bleeding, infection, or device malfunction, and not all patients may receive their advantages.
The desire for minimally invasive treatment options is rising, the prevalence of neurological illnesses is rising, and the market for neuromodulation devices is dynamic and changing quickly as a result of these and other factors.
Technological developments are one of the main factors fueling growth in the market for neuromodulation devices. To increase the security, effectiveness, and functionality of neuromodulation devices, manufacturers are spending a lot of money on research and development. In order to maximize therapeutic effectiveness while lowering the danger of adverse effects, new devices are being developed that provide more accurate targeting of particular neurons or brain regions. Additionally, a rising movement is underway to create minimally invasive devices that can be installed without requiring major surgery, which can lower the dangers connected with conventional procedures.
As per the report, the global Neuromodulation Devices Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
by Type
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Transcranial Magnetic Stimulators
• Others
by Technology
• Internal
• External
by Application
• Parkinson’s Disease
• Chronic Pain
• Migraine
• Epilepsy
• Tremor
• Depression
• Urinary & Faecal Incontinence
• Others
by Material
• Polymeric Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
by End-Use
• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in the Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Boston Scientific Corporation
• Abbott Laboratories
• Nevro Corporation
• Neuronetics, Inc.
• Medtronic Plc
*List not exhaustive
1. Executive Summary
1.1 Introduction to Neuromodulation Devices Markets
1.2 Neuromodulation Devices Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Neuromodulation Devices Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Neuromodulation Devices Market Trends
3.2 Key Neuromodulation Devices Market Growth Drivers
3.3 Key Neuromodulation Devices Market Growth Restraints
4 Neuromodulation Devices Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Neuromodulation Devices Market Segmentation- Outlook by Type
5.1 Spinal Cord Stimulators Market Outlook to 2030
5.2 Deep Brain Stimulators Market Outlook to 2030
5.3 Sacral Nerve Stimulators Market Outlook to 2030
5.4 Vagus Nerve Stimulators Market Outlook to 2030
5.5 Transcranial Magnetic Stimulators Market Outlook to 2030
5.6 Others Market Outlook to 2030
6. Neuromodulation Devices Market Segmentation- Outlook by Technology
6.1 Internal Market Outlook to 2030
6.2 External Market Outlook to 2030
7. Neuromodulation Devices Market Segmentation- Outlook by Application
7.1 Parkinson’s Disease Market Outlook to 2030
7.2 Chronic Pain Market Outlook to 2030
7.3 Migraine Market Outlook to 2030
7.4 Epilepsy Market Outlook to 2030
7.5 Tremor Market Outlook to 2030
7.6 Depression Market Outlook to 2030
7.7 Urinary & Faecal Incontinence Market Outlook to 2030
7.8 Others Market Outlook to 2030
8. Neuromodulation Devices Market Segmentation- Outlook by Material
8.1 Polymeric Biomaterial Market Outlook to 2030
8.2 Metallic Biomaterial Market Outlook to 2030
8.3 Ceramic Biomaterial Market Outlook to 2030
9. Neuromodulation Devices Market Segmentation- Outlook by End-Use
9.1 Hospitals & Ambulatory Surgery Centers (ASC) Market Outlook to 2030
9.2 Clinics & Physiotherapy Centers Market Outlook to 2030
9.3 Others Market Outlook to 2030
10. North America Neuromodulation Devices Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 North America Neuromodulation Devices Market Growth Opportunities
10.3 North America Neuromodulation Devices Market Outlook by Application
10.4 North America Neuromodulation Devices Market Outlook by Type
10.5 North America Neuromodulation Devices Market Outlook by Country
10.6 United States Neuromodulation Devices Market Outlook
10.7 Canada Neuromodulation Devices Market Outlook
10.8 Mexico Neuromodulation Devices Market Outlook
11. Europe Neuromodulation Devices Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Europe Neuromodulation Devices Market Outlook by Application
11.3 Europe Neuromodulation Devices Market Outlook by Type
11.4 Europe Neuromodulation Devices Market Outlook by Country
11.5 Germany Neuromodulation Devices Market Outlook
11.6 France Neuromodulation Devices Market Outlook
11.7 United Kingdom Neuromodulation Devices Market Outlook
11.8 Spain Neuromodulation Devices Market Outlook
11.9 Italy Neuromodulation Devices Market Outlook
11.10 Other Europe Neuromodulation Devices Market Outlook
12. Asia Pacific Neuromodulation Devices Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Asia Pacific Neuromodulation Devices Market Outlook by Application
12.3 Asia Pacific Neuromodulation Devices Market Outlook by Type
12.4 Asia Pacific Neuromodulation Devices Market Outlook by Country
12.5 China Neuromodulation Devices Market Outlook
12.6 Japan Neuromodulation Devices Market Outlook
12.7 India Neuromodulation Devices Market Outlook
12.8 Other Asia Pacific Neuromodulation Devices Market Outlook
13. Latin America Neuromodulation Devices Market Outlook and Opportunities to 2030
13.1 Market Snapshot, 2023
13.2 Latin America Neuromodulation Devices Market Outlook by Application
13.3 Latin America Neuromodulation Devices Market Outlook by Type
13.4 Latin America Neuromodulation Devices Market Outlook by Country
13.5 Brazil Neuromodulation Devices Market Outlook
13.6 Argentina Neuromodulation Devices Market Outlook
13.7 Other Latin America Neuromodulation Devices Market Outlook
14. Middle East and Africa Neuromodulation Devices Market Outlook and Opportunities to 2030
14.1 Market Snapshot, 2023
14.2 Middle East and AfricaNeuromodulation Devices Market Outlook by Application
14.3 Middle East and AfricaNeuromodulation Devices Market Outlook by Type
14.4 Middle East and AfricaNeuromodulation Devices Market Outlook by Country
14.5 Saudi Arabia Neuromodulation Devices Market Outlook
14.6 UAE Neuromodulation Devices Market Outlook
14.7 South Africa Neuromodulation Devices Market Outlook
14.8 Other Middle East and Africa Neuromodulation Devices Market Outlook
15 Profiles of major Neuromodulation Devices Companies
Boston Scientific Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Abbott Laboratories
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Nevro Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Neuronetics, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Medtronic Plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
16. Appendix
16.1 Publisher’s Expertise
16.2 List of Tables and Charts
16.3 List of Exhibits
16.4 Legal Disclaimer
by Type
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Transcranial Magnetic Stimulators
• Others
by Technology
• Internal
• External
by Application
• Parkinson’s Disease
• Chronic Pain
• Migraine
• Epilepsy
• Tremor
• Depression
• Urinary & Faecal Incontinence
• Others
by Material
• Polymeric Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
by End-Use
• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others